Cancer Gene Therapy - Table of Contents alert Volume 19 Issue 5

TABLE OF CONTENTS Volume 19, Issue 5 (May 2012) In this issue Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Blood Cancer Journal now indexed by Thomson Reuters ISI We are pleased to inform you that Blood Cancer Journal has been selected for coverage in Thomson Reuter’s products and services and will be indexed and abstracted in: - Science Citation Index Expanded (also known as SciSearch®) - Journal Citation Reports/Science Edition - Current Contents®/Clinical Medicine - Biological Abstracts - BIOSIS Previews   Original Articles Top Targeting dendritic cells with antigen via dendritic cell-associated promoters V Moulin, M E Morgan, D Eleveld-Trancikova, J B A G Haanen, E Wielders, M W G Looman, R A J Janssen, C G Figdor, B J H Jansen and G J Adema Cancer Gene Ther 2012 19: 303-311; advance online publication, February 24, 2012; 10.1038/cgt.2012.2 Abstract | Full Text Membrane-bound form of monocyte chemoattractant protein-1 enhances antitumor effects of suicide gene therapy in a model of hepatocellular carcinoma Y Marukawa, Y Nakamoto, K Kakinoki, T Tsuchiyama, N Iida, T Kagaya, Y Sakai, M Naito, N Mukaida and S Kaneko Cancer Gene Ther 2012 19: 312-319; advance online publication, March 9, 2012; 10.1038/cgt.2012.3 Abstract | Full Text Bystander killing of malignant cells via the delivery of engineered thymidine-active deoxycytidine kinase for suicide gene therapy of cancer A Neschadim, J C M Wang, A Lavie and J A Medin Cancer Gene Ther 2012 19: 320-327; advance online publication, March 2, 2012; 10.1038/cgt.2012.4 Abstract | Full Text Antitumor potential of SLPI promoter controlled recombinant caspase-3 expression in laryngeal carcinoma J Chen, B Yang, S Zhang, Y Ling, J Ye, Z Jia and J Cao Cancer Gene Ther 2012 19: 328-335; advance online publication, March 2, 2012; 10.1038/cgt.2012.5 Abstract | Full Text Intratumoral delivery of CD154 homolog (Ad-ISF35) induces tumor regression: analysis of vector biodistribution, persistence and gene expression J Melo-Cardenas, M Urquiza, T J Kipps and J E Castro Cancer Gene Ther 2012 19: 336-344; advance online publication, March 9, 2012; 10.1038/cgt.2012.6 Abstract | Full Text An artificially constructed radiation-responsive promoter is activated by doxorubicin R Ogawa, A Morii, A Watanabe, Z-G Cui, G Kagiya, N Doi, Q L Zhao and L B Feril, Jr Cancer Gene Ther 2012 19: 345-351; advance online publication, March 9, 2012; 10.1038/cgt.2012.7 Abstract | Full Text Induced transgene expression for the treatment of solid tumors by hematopoietic stem cell-based gene therapy F Noyan, I Avedillo Díez, M Hapke, C Klein and R A Dewey Cancer Gene Ther 2012 19: 352-357; advance online publication, March 9, 2012; 10.1038/cgt.2012.8 Abstract | Full Text Potential use of folate-polyethylene glycol (PEG)-appended dendrimer (G3) conjugate with α-cyclodextrin as DNA carriers to tumor cells H Arima, M Arizono, T Higashi, A Yoshimatsu, H Ikeda, K Motoyama, K Hattori, T Takeuchi, F Hirayama and K Uekama Cancer Gene Ther 2012 19: 358-366; advance online publication, March 9, 2012; 10.1038/cgt.2012.9 Abstract | Full Text Advertisement The Arab world has a rich history of scientific breakthroughs. Ensure you're part of the scientific and medical community gaining access to breaking news in the region. Access Nature Middle East - your free portal for scientific and medical research, features, jobs and events in the Arabic speaking world. www.nature.com/nmiddleeast/ Follow us: Facebook, Twitter, & Google +   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.